Pancreatic Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Pancreatic Cancer, including details on symptoms, causes, treatment, information.

Volume 1 (2004), Issue 4 (December)

1. Loss of neural cell adhesion molecule induces tumor metastasis by up-regulating lymphangiogenesis.
   Cancer Res, 64(23): 8630-8. [Abstract] [Full-text]
2. Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts.
   Cancer Res, 64(23): 8492-5. [Abstract] [Full-text]
3. Detecting changes in the relative expression of KRAS2 splice variants using polymerase colonies.
   Biotechnol Prog, 20(6): 1836-9. [Abstract] [Full-text]
4. p53 and DPC4 alterations in the bile of patients with pancreatic carcinoma.
   J Surg Oncol, 88(4): 210-6. [Abstract] [Full-text]
5. Is the chronologic age a contra-indication for surgical palliation of unresectable periampullary neoplasms?
   J Surg Oncol, 88(4): 206-9. [Abstract] [Full-text]
6. Survival of patients with periampullary carcinoma is predicted by lymph node 8a but not by lymph node 16b1 status.
   Br J Surg, 91(12): 1592-9. [Abstract] [Full-text]
7. Characterization of gene expression in mucinous cystic neoplasms of the pancreas using oligonucleotide microarrays.
   Oncogene, 23(56): 9042-51. [Abstract] [Full-text]
8. Combined therapy of experimental pancreatic cancer with CYP2B1 producing cells: low-dose ifosfamide and local tumor irradiation.
   Int J Cancer, 113(4): 649-53. [Abstract] [Full-text]
9. Proof of principle for the use of 11C-labelled peptides in tumour diagnosis with PET.
   Eur J Nucl Med Mol Imaging, 31(12): 1653-7. [Abstract] [Full-text]
10. Inhibition of SRC tyrosine kinase as treatment for human pancreatic cancer growing orthotopically in nude mice.
    Clin Cancer Res, 10(23): 8028-36. [Abstract] [Full-text]
11. Caspase-3 drives apoptosis in pancreatic cancer cells after treatment with gemcitabine.
    J Gastrointest Surg, 8(8): 1072-8. [Abstract] [Full-text]
12. Is there a role for staging laparoscopy in patients with locally advanced, unresectable pancreatic adenocarcinoma?
    J Gastrointest Surg, 8(8): 1068-71. [Abstract] [Full-text]
13. Mechanisms of resistance to Erbitux (anti-epidermal growth factor receptor) combination therapy in pancreatic adenocarcinoma cells.
    J Gastrointest Surg, 8(8): 960-9; discussion 969-70. [Abstract] [Full-text]
14. Pancreaticoduodenectomy with vascular resection: margin status and survival duration.
    J Gastrointest Surg, 8(8): 935-49; discussion 949-50. [Abstract] [Full-text]
15. Differential expression profiling of human pancreatic adenocarcinoma and healthy pancreatic tissue.
    Proteomics, 4(12): 3975-88. [Abstract] [Full-text]
16. Disseminated microvascular pulmonary tumor cell embolism: a rare cause of fulminant pulmonary hypertension.
    Onkologie, 27(6): 566-8. [Abstract] [Full-text]
17. Dominant negative inhibitors of signalling through the phosphoinositol 3-kinase pathway for gene therapy of pancreatic cancer.
    Gut, 54(1): 109-16. [Abstract] [Full-text]
18. A prospective randomized study of gemcitabine with doxifluridine versus paclitaxel with doxifluridine in concurrent chemoradiotherapy for locally advanced pancreatic cancer.
    Int J Radiat Oncol Biol Phys, 60(5): 1494-501. [Abstract] [Full-text]
19. Chromosomal alterations detected by comparative genomic hybridization in nonfunctioning endocrine pancreatic tumors.
    Cancer Genet Cytogenet, 156(1): 23-30. [Abstract] [Full-text]
20. Fine-needle aspiration cytology of intraductal papillary-mucinous tumors: a retrospective analysis.
    Diagn Cytopathol, 32(1): 16-20. [Abstract] [Full-text]
21. Risk factors associated with earlier age of onset in familial pancreatic carcinoma.
    Cancer, 101(12): 2722-6. [Abstract] [Full-text]
22. Heterogeneity of risk for melanoma and pancreatic and digestive malignancies: a melanoma case-control study.
    Cancer, 101(12): 2809-16. [Abstract] [Full-text]
23. Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis.
    Cancer, 101(12): 2727-36. [Abstract] [Full-text]
24. Impaired function of circulating dendritic cells in patients with pancreatic cancer.
    Clin Immunol, 114(1): 52-60. [Abstract] [Full-text]
25. Surgery of resectable nonfunctioning neuroendocrine pancreatic tumors.
    World J Surg, 28(12): 1248-60. [Abstract] [Full-text]
26. Laparoscopic pancreatic surgery for islet cell tumors of the pancreas.
    World J Surg, 28(12): 1239-47. [Abstract] [Full-text]
27. Prospective evaluation of imaging procedures for the detection of pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1.
    World J Surg, 28(12): 1317-22. [Abstract] [Full-text]
28. Current concepts in functioning endocrine tumors of the pancreas.
    World J Surg, 28(12): 1231-8. [Abstract] [Full-text]
29. Metabolic sensitivity of pancreatic tumour cell apoptosis to glycogen phosphorylase inhibitor treatment.
    Br J Cancer, 91(12): 2094-100. [Abstract] [Full-text]
30. MUC1 expression in primary and metastatic pancreatic cancer cells for in vitro treatment by (213)Bi-C595 radioimmunoconjugate.
    Br J Cancer, 91(12): 2086-93. [Abstract] [Full-text]
31. Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry.
    Cancer Res, 64(24): 9018-26. [Abstract] [Full-text]
32. The minimal active domain of endostatin is a heparin-binding motif that mediates inhibition of tumor vascularization.
    Cancer Res, 64(24): 9012-7. [Abstract] [Full-text]
33. Phase I trial using weekly administration of gemcitabine and docetaxel in patients with advanced pancreatic carcinoma.
    Chemotherapy, 50(6): 289-96. [Abstract] [Full-text]
34. Gemcitabine and ISIS-2503 for patients with locally advanced or metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II trial.
    J Clin Oncol, 22(24): 4944-50. [Abstract] [Full-text]
35. Intrapancreatic pseudoaneurysm associated with pancreatitis mimicking pancreatic tumor.
    J Gastroenterol Hepatol, 20(1): 159-61. [Abstract] [Full-text]
36. Patterns of K-ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by microdissection, PCR and direct sequencing.
    J Gastroenterol Hepatol, 20(1): 67-72. [Abstract] [Full-text]
37. Impact of gemcitabine on the treatment of metastatic pancreatic cancer.
    J Gastroenterol Hepatol, 20(1): 62-6. [Abstract] [Full-text]
38. Spontaneous rupture of pancreatic metastasis from renal cell carcinoma.
    Jpn J Clin Oncol, 34(11): 696-9. [Abstract] [Full-text]
39. Chemoradiotherapy for pancreatic cancer: current status and perspectives.
    Int J Clin Oncol, 9(6): 451-7. [Abstract] [Full-text]
40. Cancer in the elderly: pancreatic cancer.
    Surg Oncol, 13(4): 201-10. [Abstract] [Full-text]
41. Ductal cells of the pancreas.
    Int J Biochem Cell Biol, 37(3): 504-10. [Abstract] [Full-text]
42. Intraductal oncocytic papillary neoplasm of the pancreas with celiac artery compression syndrome and a jejunal artery aneurysm: report of a case.
    Surg Today, 35(1): 86-90. [Abstract] [Full-text]
43. Primary anaplastic large cell lymphoma of the pancreas.
    Leuk Lymphoma, 46(3): 457-9. [Abstract] [Full-text]
44. Inhibition of cell growth by overexpression of manganese superoxide dismutase (MnSOD) in human pancreatic carcinoma.
    Free Radic Res, 38(11): 1223-33. [Abstract] [Full-text]
45. Preparation and biological evaluation of copper-64-labeled tyr3-octreotate using a cross-bridged macrocyclic chelator.
    Clin Cancer Res, 10(24): 8674-82. [Abstract] [Full-text]
46. MAP2K4/MKK4 expression in pancreatic cancer: genetic validation of immunohistochemistry and relationship to disease course.
    Clin Cancer Res, 10(24): 8516-20. [Abstract] [Full-text]
47. Impact of vascular endothelial growth factor-C and -D expression in human pancreatic cancer: its relationship to lymph node metastasis.
    Clin Cancer Res, 10(24): 8413-20. [Abstract] [Full-text]
48. Intraductal papillary mucinous neoplasm of the pancreas in a patient with attenuated familial adenomatous polyposis.
    J Clin Pathol, 58(1): 97-101. [Abstract] [Full-text]
49. F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: a prospective study.
    J Gastrointest Surg, 9(1): 22-8; discussion 28-9. [Abstract] [Full-text]

© 2004-2008 Pancreatic Cancer Research Today. All Rights Reserved.